Venixxa (Venoactive Treatment) is an OTC medication used to reduce lower-leg edema associated with mild-to-moderate chronic venous disease; helps to relieve signs and symptoms of mild-to-moderate chronic venous disease, such as varicose and spider veins, pain in the legs, sensation of heaviness, sensation of swelling, and functional discomfort. Venixxa is also used to reduce signs and symptoms associated with hemorrhoids, such as anal discharge, bleeding, discomfort, inflammation (proctitis), itching (pruritus), pain, redness (erythema), sensation of needing to pass stools (tenesmus), and swelling (edema) and helps to reduce the duration, intensity, and recurrence of acute hemorrhoidal episodes. You should consult a healthcare practitioner for use beyond 2 months.
Manufacturer Information
Canadian Pharmacy King currently offers the brand Venixxa from Canada by Servier. Venixxa Chronic Venous Disease tablets are available in the strength of 500 mg/30 tab and Venixxa Hemorrhoidal Disease tablets are available in the strength of 500 mg/36 tab. The generic alternative is currently unavailable.
Common side effects of Venixxa may include hypersensitivity/allergy, gastrointestinal discomfort, dizziness, headaches, malaise, and skin reactions. Call your doctor immediately if you notice more serious side effects. This is not a complete list of side effects, and others may occur. Contact your doctor if any of these side effects worsen or persist.
Treatment should be avoided during pregnancy and breastfeeding. The patient should be advised to consult a healthcare practitioner if symptoms of chronic venous disease persist or worsen, or in the event of inflammation of the skin, thrombophlebitis or subcutaneous induration, severe pain, ulcers, sudden swelling of one or both legs, cardiac or renal insufficiency or disorder. Tell your doctor or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.
Check out our latest Blog Post
How to Become a Centenarian: What We Can Learn from Geroscience